| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/2011 | CN101945894A Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| 01/12/2011 | CN101945889A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/12/2011 | CN101945887A Cationic core-shell peptide nanoparticles |
| 01/12/2011 | CN101942470A Methods for preventing gluconoylation of proteins |
| 01/12/2011 | CN101942462A Preparation method and use of insecticidal synergistic protein |
| 01/12/2011 | CN101942460A Arabidopsis AtACDO1 gene and expression system and application thereof |
| 01/12/2011 | CN101942459A Cotton TRY gene |
| 01/12/2011 | CN101942453A Molecular identification method based on transfer of GAI mRNA molecules between pear rootstock and scion |
| 01/12/2011 | CN101942451A Application of rice OsAPI5 gene in fertility control |
| 01/12/2011 | CN101942450A Vacuolar Na+/H+ antiporter gene of strong xerophil zygophyllumxanthoxylum, plant expression vector and plant genetic transformation method thereof |
| 01/12/2011 | CN101942449A Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 01/12/2011 | CN101942448A Novel functions of salt and drought tolerance of cotton nodulin-like gene and application thereof |
| 01/12/2011 | CN101942443A Novel beta-actin and rps21 promoters and uses thereof |
| 01/12/2011 | CN101942442A Novel beta-actin and rps21 promoters and uses thereof |
| 01/12/2011 | CN101942019A Factor VII or VIIa polypeptide variants |
| 01/12/2011 | CN101942018A Analogues of GLP-1 |
| 01/12/2011 | CN101942017A Novel tumor marker |
| 01/12/2011 | CN101942016A Rice protein OsCPN1 as well as encoding gene and application thereof |
| 01/12/2011 | CN101942015A Rice protein OsSRA2 and coding gene and applications thereof |
| 01/12/2011 | CN101942014A Food grade phycocyanin and preparation method thereof |
| 01/12/2011 | CN101942013A HLA-DR9 restrictive regulatory T cell epitope of Hepatitis B virus core antigen and e antigen and application thereof |
| 01/12/2011 | CN101942012A Polypeptide for preventing and treating angiogenesis and application thereof |
| 01/12/2011 | CN101942011A Neutralizing epitope of human adenovirus type 3 (HAdV-3) and type 7 (HAdV-7) and application thereof |
| 01/12/2011 | CN101941946A Disubstituted benzene uracil peptide nucleic acid monomer and intermediate as well preparation methods and applications thereof |
| 01/12/2011 | CN101940189A Transgenic trasnchromosomal rodents for making human antibodies |
| 01/12/2011 | CN101619316B Functional gene Rdr-onc sequence of rana chensinensis onconase sample, construction method, amino acid sequence thereof and application thereof |
| 01/12/2011 | CN101531713B Bt protein Cry56Aal as well as encoding gene thereof and application thereof |
| 01/12/2011 | CN101531711B Bt protein Cry52Bal as well as encoding gene thereof and application thereof |
| 01/12/2011 | CN101302516B Modified pig alpha-interferon genes, construction of expression vector and preparation of protein thereof |
| 01/12/2011 | CN101270156B Mutation saccharomyces cerevisiae hansen initiation transcription factor,encoding gene and application thereof |
| 01/12/2011 | CN101148473B Recombination human insulin and its coding gene and application |
| 01/12/2011 | CN101081863B Lipopolysaccharide conjugated protein and monoclonal antibody and usage |
| 01/12/2011 | CN101033254B Method of purifying and combining human interleukins 12 |
| 01/12/2011 | CN101029081B Recombinant incretin peptide and method for constructing and culturing producing strain |
| 01/11/2011 | US7868168 High viscosity xanthan polymer preparations |
| 01/11/2011 | US7868156 cultivating a transgenic plant containing a nucleotide sequences coding polypeptide, proteins and other products of interest; controlling expression of nucleic acid sequences; product is produced in seed of the plant; increase the oleic acid content of rapeseed oil |
| 01/11/2011 | US7868154 Promoter to IL-18BP, its preparation and use |
| 01/11/2011 | US7868151 Recombinant human interferon-like proteins |
| 01/11/2011 | US7868150 Nucleic acids encoding T2R taste receptors |
| 01/11/2011 | US7868148 Using transposon vector as gene transfer and amplification tool; gene therapy |
| 01/11/2011 | US7868146 Method and device for producing a thread from silk proteins |
| 01/11/2011 | US7868138 mutant green fluorescent protein (GFP) with enhanced fluorescent intensity as compared to wild type Aequorea victoria GFP; use of repeated cycles of mutagenesis, in vivo recombination and selection which allow for the directed molecular evolution in vivo and in vitro of highly complex linear sequences |
| 01/11/2011 | US7868137 Search for cancer markers by a novel screening method |
| 01/11/2011 | US7868136 Search for cancer markers by a screening method |
| 01/11/2011 | US7868134 Immunogenic peptides derived from sclerostin |
| 01/11/2011 | US7868133 For diagnosis, treatment, and prevention of apoptosis associated disorders using animal models; for drug screening; chimeras; genetic engineering, cancer |
| 01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
| 01/11/2011 | US7867976 Nogo epitopic fragments for modulating immune response |
| 01/11/2011 | US7867975 administering a nucleic acid comprising a coding region encoding endostatin; inhibiting angiogenesis in an angiogenesis-dependent site associated with macular degeneration; antiproliferative, anticarcinogenic and antitumor agents |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | US7867764 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum that comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 01/11/2011 | US7867743 phytases derived from Citrobacter braakii, belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed |
| 01/11/2011 | US7867739 process to protect and/or increase the specific activity of an enzyme (nitrilase) catalyst comprising a polypeptide having nitrilase activity when converting glycolonitrile to glycolic acid by conducting the reaction in the presence of an amine protectant |
| 01/11/2011 | US7867738 Process for enzymatically converting glycolonitrile to glycolic acid |
| 01/11/2011 | US7867737 process to protect and/or increase the specific activity of an enzyme (nitrilase) catalyst comprising a polypeptide having nitrilase activity when converting glycolonitrile to glycolic acid by conducting the reaction in the presence of an amine protectant |
| 01/11/2011 | US7867732 high-mannose-type sugar chain bound to a chicken antibody; BML-17; useful in medical, pharmaceutical industries, and industries relating to test agents |
| 01/11/2011 | US7867731 HX2004-6 polypeptide expressed in cancerous cells |
| 01/11/2011 | US7867721 detects mechanical stimuli and convert them into electrical signals; used to diagnose and treat Meniere's disease, sensorineural deafness, blood pressure disorders and cancer |
| 01/11/2011 | US7867704 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections |
| 01/11/2011 | US7867699 inexpensively synthesizing large quantities of an essentially pure, biologically active, glycosylated Dkk protein, including mammalian and human Dkk proteins |
| 01/11/2011 | US7867519 Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio |
| 01/11/2011 | US7867502 Genetic engineered polypeptides; useful candidates in a vaccine against tuberculosis (TB) or diagnostic preparation for TB; vaccine; inhibit mycobacterial virulence |
| 01/11/2011 | US7867501 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/11/2011 | US7867500 A carrier and a steroid receptor coactivator-1 and transcription intermediary factor-2 Associated Modulatory Protein (STAMP) that can modulate transcription of glucocorticoid-, progesterone-, mineralocorticoid- and androgen-responsive genes; conception (contraception), infertility, diabetes, cancer etc |
| 01/11/2011 | US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization |
| 01/11/2011 | US7867482 treating cancer responsive to interferon alpha therapy; the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b) |
| 01/11/2011 | US7867481 Method of treating anemia by administering IL-1ra |
| 01/11/2011 | US7867475 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/11/2011 | CA2429303C Promoter for the functional characterization of g protein-coupled receptors in the yeast saccharomyces cerevisiae |
| 01/11/2011 | CA2349406C Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 01/11/2011 | CA2340324C Improved expression of cry3b insecticidal protein in plants |
| 01/11/2011 | CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/10/2011 | CA2709340A1 Mutations in the influenza a virus ns1 gene and use thereof |
| 01/06/2011 | WO2011003100A2 Compositions and methods for diagnosing and/or treating influenza infection |
| 01/06/2011 | WO2011003085A1 Hyr1 as a target for active and passive immunization against candida |
| 01/06/2011 | WO2011002931A2 Markers of xmrv infection and uses thereof |
| 01/06/2011 | WO2011002525A1 Methods for treatment of muscular dystrophy |
| 01/06/2011 | WO2011002077A1 Tnf-α gene therapy agent contained in polymeric micelle |
| 01/06/2011 | WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein |
| 01/06/2011 | WO2011002066A1 Peptide and use thereof |
| 01/06/2011 | WO2011001882A1 Flagellin mutant capable of effectively inducing protective capability on infection by pseudomonas aeruginosa |
| 01/06/2011 | WO2011001413A1 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor |
| 01/06/2011 | WO2011001403A1 Protein with apoptotic activity on cancer cells, its preparation and use |
| 01/06/2011 | WO2011001366A1 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease |
| 01/06/2011 | WO2011001191A1 Method for the detection of organ or tissue injury |
| 01/06/2011 | WO2011001152A1 T cell receptors |
| 01/06/2011 | WO2011001086A2 Use of interfering rna for treating an hiv infection |
| 01/06/2011 | WO2011000933A2 Enhanced phytase variants |
| 01/06/2011 | WO2011000929A1 Neurotoxins exhibiting shortened biological activity |
| 01/06/2011 | WO2011000860A2 Targets for retrovirus associated diseases |
| 01/06/2011 | WO2011000823A1 Insulin derivatives |
| 01/06/2011 | WO2011000108A1 Compositions and methods for silencing apolipoprotein b |
| 01/06/2011 | WO2011000095A1 Multimeric peptide conjugates and uses thereof |
| 01/06/2011 | WO2011000026A1 Terpene synthases from santalum |
| 01/06/2011 | WO2010121351A8 Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy |
| 01/06/2011 | WO2010115133A3 Newcastle disease virus vectored avian vaccines |
| 01/06/2011 | WO2010104761A3 Anti-cd40 antibodies and uses thereof |
| 01/06/2011 | WO2010103546A3 A polynucleotide and polypeptide sequence and methods thereof |
| 01/06/2011 | WO2010102085A4 Stabilized reverse transcriptase fusion proteins |